These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37642706)

  • 1. Preclinical evaluation of a dual-receptor targeted tracer [
    Lv X; Song X; Long Y; Zeng D; Lan X; Gai Y
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):54-67. PubMed ID: 37642706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Characterization of 4
    Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
    J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of albumin binder-conjugated heterodimeric radiopharmaceuticals targeting integrin α
    Yang B; Shan C; Song X; Lv X; Long Y; Zeng D; An R; Lan X; Gai Y
    Eur J Nucl Med Mol Imaging; 2024 Sep; 51(11):3334-3345. PubMed ID: 38787395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of [
    Liu N; Wan Q; Wu X; Zhao T; Jakobsson V; Yuan H; Chen X; Zhang J; Zhang W
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1685-1697. PubMed ID: 38246909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, preclinical, and initial clinical evaluation of integrin α
    Wen X; Wang R; Xu P; Shi M; Shang Q; Zeng X; Zeng X; Liu J; Wang X; Zhu Z; Guo Z; Chen X; Zhang J
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2023-2035. PubMed ID: 38376806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
    Li ZB; Chen K; Chen X
    Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
    Liu Z; Yan Y; Liu S; Wang F; Chen X
    Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR).
    Máté G; Kertész I; Enyedi KN; Mező G; Angyal J; Vasas N; Kis A; Szabó É; Emri M; Bíró T; Galuska L; Trencsényi G
    Eur J Pharm Sci; 2015 Mar; 69():61-71. PubMed ID: 25592229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a CD13 and Integrin α
    Long Y; Shao F; Ji H; Song X; Lv X; Xia X; Liu Q; Zhang Y; Zeng D; Lan X; Gai Y
    Front Oncol; 2022; 12():884554. PubMed ID: 35664759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of aminopeptidase N (APN/CD13) specificity of different
    Kis A; Dénes N; Szabó JP; Arató V; Jószai I; Enyedi KN; Lakatos S; Garai I; Mező G; Kertész I; Trencsényi G
    Int J Pharm; 2020 Nov; 589():119881. PubMed ID: 32946975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [
    Lu Q; Long Y; Fan K; Shen Z; Gai Y; Liu Q; Jiang D; Cai W; Wan C; Lan X
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4000-4013. PubMed ID: 35763056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective head-to-head comparison of
    Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhu Z
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4218-4227. PubMed ID: 35657429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin α
    Li H; Peng W; Zhen Z; Zhang W; Liao S; Wu X; Wang L; Xuan A; Gao Y; Xu J
    Nucl Med Biol; 2023; 124-125():108364. PubMed ID: 37591041
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Szabo JP; Denes N; Arato V; Racz S; Kis A; Opposits G; Kepes Z; Hajdu I; Joszai I; Emri M; Kertesz I; Mezo G; Trencsenyi G
    In Vivo; 2022; 36(4):1667-1675. PubMed ID: 35738627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
    Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
    Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chen CJ; Chan CH; Lin KL; Chen JH; Tseng CH; Wang PY; Chien CY; Yu HM; Lin WJ
    Nucl Med Biol; 2019; 68-69():22-30. PubMed ID: 30578136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the monomeric [
    Israel I; Elflein K; Schirbel A; Chen K; Samnick S
    Eur J Pharm Sci; 2021 Nov; 166():105964. PubMed ID: 34375678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.
    Liu Z; Niu G; Shi J; Liu S; Wang F; Liu S; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):947-57. PubMed ID: 19159928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.